- Investing Ideas
- Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
3
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
3 companies
Abbott India
Market Cap: ₹557.4b
Operates as a pharmaceutical company in India.
500488
₹26,232.80
7D
2.6%
1Y
-23.6%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹408.3b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,409.90
7D
-2.2%
1Y
-27.0%
Sanofi India
Market Cap: ₹77.8b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,379.25
7D
-2.2%
1Y
-43.7%